Update on pathobiology
S.A. Pileri
The role of ibrutinib in the actual and future therapeutic algorithm
M. Wang
The other new BTK inhibitors
C. Tam
The other agents...
P. Martin
The “combo”: ibrutinib plus Venetoclax
C. Tam
The role of CAR-T cell
S.J. Schuster, M. Wang
Privacy Policy | Cookie Policy